Lupus nephritis: pathologic features, epidemiology and a guide to therapeutic decisions

Ortega, L. M.; Schultz, D. R.; Lenz, O.; Pardo, V.; Contreras, G. N.
April 2010
Lupus;Apr2010, Vol. 19 Issue 5, p557
Academic Journal
Systemic lupus erythematosus may present with renal manifestations that frequently are difficult to categorize and lupus nephritis is an important predictor of poor outcome. The type and spectrum of renal injury may remain undiagnosed until full-blown nephritic and/or nephrotic syndrome appear with increased risk of end-stage renal disease. These abnormalities occur within the first few years after the diagnosis of lupus is made on clinical grounds and with the support of laboratory tests in high risk patients. An early renal biopsy is helpful in patients with an abnormal urinalysis and/or reduced glomerular filtration rate and the results form the basis for therapeutic decisions. The biopsy also provides vital prognostic information based on histological categorization of different types of lupus nephritis, the degree of activity, chronicity and the immunopathogenesis. In the current armamentarium, the use of cyclophosphamide and azathioprine and recently mycophenolate mofetil, reduce morbidity and maintenance therapies reduce the risk of end-stage renal disease. Clinical trials underway promise new, effective and safe immunosuppressive regimens for the treatment of proliferative lupus nephritis.


Related Articles

  • Lupus nephritis in Chinese children — a territory-wide cohort study in Hong Kong. Sik-Nin Wong; Kei-Chiu Tse; Tsz-Leung Lee; Kwok-Wai Lee; Chim, Stella; Kwok-Piu Lee; Chu, Reann Wai-Po; Chan, Winnie; Kwok-Wah Fong; Hui, Joannie; Li, Samantha Po-Siu; Pa-Shing Yeung; So-Fun Yuen; Ho, Assunta Chi-Hang; Leung, Lettie Chuk-Kwan; Luk, David; Shu-Yan Chan; Hon-Ming Cheung; Chung-Mo Chow; Lau, David // Pediatric Nephrology;Aug2006, Vol. 21 Issue 8, p1104 

    We report a multicenter study of Chinese children in Hong Kong with systemic lupus erythematosus (SLE) nephritis. Children were included if: they fulfilled the ACR criteria, had significant proteinuria or casturia, were Chinese and younger than 19 years and had been diagnosed with SLE between...

  • Prediction of urinary protein markers in lupus nephritis. Oates, Jim C.; Varghese, Sanju; Bland, Alison M.; Taylor, Timothy P.; Self, Sally E.; Stanislaus, Romesh; Almeida, Jonas S.; Arthur, John M. // Kidney International;Dec2005, Vol. 68 Issue 6, p2588 

    Background: Lupus nephritis is divided into six classes and scored according to activity and chronicity indices based on histologic findings. Treatment differs based on the pathologic findings. Renal biopsy is currently the only way to accurately predict class and activity and...

  • Mycophenolate mofetil and intravenous cyclophosphamide are similar as induction therapy for class V lupus nephritis. Radhakrishnan, Jai; Moutzouris, Dimitrios-Anestis; Ginzler, Ellen M.; Solomons, Neil; Siempos, Ilias I.; Appel, Gerald B. // Kidney International;Jan2010, Vol. 77 Issue 2, p152 

    Class V lupus nephritis (LN) occurs in one-fifth of biopsy-proven cases of systemic lupus erythematosus. To study the effectiveness of treatments in this group of patients, we pooled analysis of two large randomized controlled multicenter trials of patients with diverse ethnic and racial...

  • Lupus vasculopathy: Diagnostic, pathogenetic and therapeutic considerations. Gonzalez-Suarez, ML; Waheed, AA; Andrews, DM; Ascherman, DP; Zeng, X; Nayer, A // Lupus;Apr2014, Vol. 23 Issue 4, p421 

    A rare form of vascular disease in systemic lupus erythematosus (SLE), lupus vasculopathy is characterized by necrosis and accumulation of immunoglobulins (IGs) and complements in the wall of arterioles and small arteries resulting in luminal narrowing. Lupus vasculopathy often accompanies lupus...

  • Effect of low-dose cyclosporine A in the treatment of refractory proteinuria in childhood-onset lupus nephritis. Baca, Vicente; Catalán, T.; Villasís-Keever, M.; Ramón, G.; Morales, A. M.; Rodríguez-Leyva, F. // Lupus;2006, Vol. 15 Issue 8, p490 

    We performed a prospective study to evaluate the efficacy and safety of low-dose cyclosporine A (CSA) treatment in paediatric lupus nephritis refractory to conventional therapy. Seven children with biopsy-proven Class III–IV lupus nephritis were treated with CSA (2–4 mg/kg/day)...

  • Recent advances in the treatment of lupus nephritis. Uchida, Keiko; Nitta, Kosaku // Clinical & Experimental Nephrology;Apr2012, Vol. 16 Issue 2, p202 

    Lupus nephritis is a common complication of systemic lupus erythematosus (SLE) which is associated with significant morbidity and mortality. The concept of two phases of therapy for lupus nephritis, such as an induction phase and a maintenance phase, is widely accepted. Since the renal...

  • Concentration-controlled treatment of lupus nephritis with mycophenolate mofetil. Daleboudt, GMN; Reinders, MEJ; Hartigh, J den; Huizinga, TWJ; Rabelink, AJ; de Fijter, JW; Berger, SP // Lupus;Feb2013, Vol. 22 Issue 2, p171 

    The article presents a retrospective study which examines the effect of concentration-controlled treatment on mycophenolic acid (MPA) exposure and renal outcome in patients with lupus nephritis. It mentions the administration of intravenous cyclophosphamide to 16 systemic lupus erythematosus...

  • Renal Biopsy: A much needed tool in patients with Systemic Lupus Erythematosis (SLE). Mahmood, Sumbal Nasir; Mukhtar, Kunwer Naveed; Deen, Saima; Khan, Faiza Nafees // Pakistan Journal of Medical Sciences;Jan/Feb2016, Vol. 32 Issue 1, p70 

    Background and Objective: Systemic lupus erythematosis (SLE) is an inflammatory disorder associated with significant morbidity and mortality. Kidneys are frequently affected in SLE and various stages of lupus nephritis have been identified based on severity of the disease. Treatment varies with...

  • ARTRITA TUBERCULOASă A GENUNCHIULUI - O COMPLICAÅ£IE RARă SURVENIND LA O PACIENTă CU LUPUS ERITEMATOS SISTEMIC. Soare, Alina; Gherghe, Ana Maria; Comărniceanu, Antoaneta; Dobrotă, Rucsandra; Mihai, Carina // Romanian Journal of Rheumatology;2013, Vol. 22 Issue 3, p174 

    The risk of active tuberculosis (TB) is increased in patients with systemic autoimmune diseases, the more so in those with severe organ/system involvement and high disease activity, requiring aggressive immunosuppressive treatment. In the following paper we are presenting the case of a female...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics